Clinical Trials Browser

Phase 2 × becatecarin × Gastrointestinal × Clear all

NCT00005085 2013-02-11

Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00005997 2010-06-11

Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer

Phase 2 Terminated

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms